bioMerieux (France), Eiken Chemical Co. Ltd (Japan), Hologic Gene-Probe (U.S.), Lucigen (U.S.), Meridian Bioscience, Inc. (U.S.), New England Biolabs, Inc. (England), Novartis Diagnostics (Spain), Nugen (U.S.), QIAGEN (The Netherlands)
(PRWEB) October 29, 2014
The “Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018” provides a detail overview of major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global Isothermal Nucleic Acid Amplification technology market along with the estimates and forecast of revenue and share analysis.
Browse 31 market data tables and 53 figures spread through 215 pages and in-depth TOC on "Isothermal Nucleic Acid Amplification Technology (INAAT) Market"
Early buyers will receive 10% customization on this report.
The global isothermal nucleic acid amplification technology (INAAT) market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. The increasing demand for enhanced molecular testing using INAAT as well as rising incidence of infectious diseases is driving market growth over the conventional thermal polymerase chain reaction (PCR) technology.
Do Inquiry For Further Details @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=839
The study covers different product, application, and end-user segments of the global isothermal nucleic acid amplification technology market. The INAAT product segment is categorized into reagent and instrument sub-segments, whereas the INAAT application segment is classified into infectious diseases, blood screening and research sub-segments. The scope of the end-users study of isothermal nucleic acid amplification technology includes hospitals, reference laboratories and others sub-segments.
Amongst various application areas, INAAT is widely used for the detection of infectious diseases; it is expected to grow at the highest CAGR of 14.4% during the forecast period due to high incidence rate of various infectious diseases such as HIV and hepatitis A & B globally. On the other hand, rapid emergence of reference laboratories and rising importance of isothermal technology in different complex molecular testing are expected to ensure a significant adoption of technologies in reference laboratory.
Infectious disease was found to be the highest revenue generating segment of the global INAAT market in 2013; it accounted for the largest share of 57.2% of the global INAAT market in 2013 and is expected to grow at 14.4% CAGR during the forecast period. The significant growth of infectious disease application market is attributed to high incidence of various infectious diseases such as HIV and hepatitis A & B and increasing adoption of INAAT in infection detection globally. In addition to infectious disease application, the study also found an emerging scope of isothermal technology in blood screening application to ensure the quality of donated blood through its early prognosis of pathogen, whereas adoption of INAAT is still limited in research application globally. Increasing adoption in cancer research, whole genome amplification, mutation, SNP detection and expression analysis is expected to drive the INAAT research application market.
Get PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=839
North America commanded the largest market share of about 44% in 2013; it is poised to grow at a CAGR of 13.3% during the forecast period. Asian INAAT market is expected to witness the highest CAGR due to increasing prevalence of infectious diseases and governments’ initiative behind the rapid adoption of novel technologies in molecular testing. Leading players in the global INAAT market are also expected to capitalize on the unmet needs in emerging nations such as India, China, South Africa, Singapore, and Middle East in the coming years.
The key players in the market include Alere, Inc. (U.S.), Becton, Dickinson & Company (U.S.), BioHelix (U.S.), bioMerieux (France), Hologic Gene-Probe (U.S.), and QIAGEN (The Netherlands).
Browse Related Reports:
Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018
Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets